Erratum to: Caveolin-1 Mediates Inflammatory Breast Cancer Cell Invasion via the Akt1 Pathway and RhoC GTPase: RhoC AND CAVEOLIN-1 IN INFLAMMATORY BREAST CANCER (Journal of Cellular Biochemistry, (2015), 116, 6, (923-933), 10.1002/jcb.25025);Caveolin-1 mediates inflammatory breast cancer cell invasion via the Akt1 pathway and RhoC GTPase

Journal of Cellular Biochemistry

Volumn 116, Issue 6, 2015, Pages 923-933

  Oglekar, Madhura ^a,b   Elbazanti, Weam O ^a,b   Weitzman, Matthew D ^a,b   Lehman, Heather L ^a,b   Van Golen, Kenneth L ^a,b  

^a UNIVERSITY OF DELAWARE   (United States)

^b HELEN F GRAHAM CANCER CENTER   (United States)

Author keywords

CAVEOLIN 1; INFLAMMATORY BREAST CANCER; INVASION; METASTASIS; RhoC GTPase

Indexed keywords

CAVEOLIN 1; KI 67 ANTIGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN AKT1; PROTEIN KINASE B; PROTEIN RHOC; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER CELL LINE; BREAST EPITHELIUM CELL; CANCER CELL; CELL INVASION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INFLAMMATORY BREAST CANCER; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ANIMAL; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; RADIATION RESPONSE; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; CAVEOLIN 1; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATORY BREAST NEOPLASMS; MICE; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS C-AKT; RHO GTP-BINDING PROTEINS; RNA, SMALL INTERFERING;

EID: 84926663091     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25876     Document Type: Erratum

References (50)

1. Aleviszos L, Kataki A, Derventzi A, Gomatos I, Loutraris C, Gloustianou G, Manouras A, Konstadoulakis MM, Zografos G,. 2014. Breast cancer nodal metastasis correlates with tumor and lymph node methylation profiles of caveolin-1 and CXCR4. Clin Exp Metastasis 31: 511-520.
2. Arapaia E, et al. 2012. The interaction between caveoln-1 and Rho- GTPases promote metastasis by controlling the expression of alpha5-integrin and the activaion of Src, Ras and Erk. Oncogene 31: 884-896.
3. Brewer TM, et al. 2013. Statin use in primary inflammatory breast cancer: A cohort study. Br J Cancer 109 (2): 318-324.
4. Brouet A, et al. 2001. Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins. Circ Res 89 (10): 866-873.
5. Chatterjee M, van Golen KL,. 2011. Farnesyl transferase inhibitor treatment of breast cancer cells leads to altered RhoA and RhoC GTPase activity and induces a dormant phenotype. Int J Cancer. 129 (1): 61-69.
6. Clark EA, Golub TR, Lander ES, Hynes RO,. 2000. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406 (6795): 532-535.
7. Davies S, van Golen KL, Hu H, Ethier SP, Merajver S,. 1998. Identification of genes differentially methylated in inflammatory breast cancer. Proc AACR 39: 94.
8. Dias SMG, Cerione RA,. 2007. X-ray crystal sturctures reveal two actived states for RhoC. Biochemistry 46: 6547-6558.
9. Elsheikh SE, et al. 2008. Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype. Br J Cancer 99 (2): 327-334.
10. Ethier SPK KE, Ridings JW, Dilts CA,. 1996. ErbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line. Cancer Res 56: 899-907.
11. Etienne-Manneville S, Hall A,. 2002. Rho GTPases in cell biology. Nature 420 (6916): 629-635.
12. Fiucci G, Ravid D, Reich R, Liscovitch M,. 2002. Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells. Oncogene 21 (15): 2365-2375.
13. Folgueira MAAK, et al. 2013. Markers of breast cancer stromal fibroblasts in primary tumor site asscociated with lymph node metastasis: a systematic review including our case series. Biosci Rep 33: 921-929.
14. Gingras D, Gauthier F, Lamy S, Desrosiers RR, Beliveau R,. 1998. Localization of RhoA GTPase to endothelial caveolae-enriched membrane domains. Biochem. Biophys. Res Commun 247 (3): 888-893.
15. Hall CL, et al. 2008. Type I Collagen receptor (alpha2beta1) signaling promotes prostate cancer cell invasion through RhoC GTPase. Neoplasia 10 (8): 797-803.
16. Jang IH, et al. 2001. Localization of phospholipase C-gamma1 signaling in caveolae: importance in EGF-induced phosphoinositide hydrolysis but not in tyrosine phosphorylation. FEBS Lett 491 (1-2): 4-8.
17. Joglekar M, van Golen KL,. 2012. Molecules that drive the invasion and metastasis of inflammatory breast cancer. In:, Ueno NTC M, editor. Inflammatory breast cancer: An update. New York, NY USA: Springer. pp 161-184.
18. Kjoller L, Hall A,. 1999. Signaling to Rho GTPases. Exp Cell Res 253 (1): 166-179.
19. Lehman HL, Van Laere SJ, van Golen CM, Vermeulen PB, Dirix LY, van Golen KL,. 2012. Regulation of inflammatory breast cancer cell invasion through Akt1/PKBalpha phosphorylation of RhoC GTPase. Mol Cancer Res 10 (10): 1306-1318.
20. Lehman HL, Dashner EJ, Lucey M, Vermeulen P, Dirix L, van Laere S, van Golen KL,. 2013. Modeling and characterization of inflammatory breast cancer emboli grown in vitro. Int J Cancer. 132 (10): 2283-2294.
21. Lehman HL, et al. 2012. Regulation of Inflammatory breast cancer cell invasion through Akt1/PKBalpha phosphorylation of RhoC GTPase. Mol Cancer Res 10 (10): 1306-1318.
22. Li L, Ren CH, Tahir SA, Ren C, Thompson TC,. 2003. Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A. Mol Cell Biol 23 (24): 9389-9404.
23. Lin M, DiVito MM, Merajver SD, Boyanapalli M, van Golen KL,. 2005. Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and caveolin-1. Mol Cancer 4 (1): 21.
24. Lucey M, Unger H, Dashner EJ, van Golen KL,. 2010. RhoC GTPase activation assay. J Vis Exp 22 (42): 2083.
25. Matthews LC, Taggart MJ, Westwood M,. 2008. Modulation of caveolin- 1 expression can affect signalling through the phosphatidyl 3-kinase/Akt pathway and cellular proliferation in response to insulin-like growth factor I. Endocrinology 149 (10): 5199-5208.
26. Mercier I, Lisanti MP,. 2012. Caveolin-1 and breast cancer: A new clinical prespective. In:, Jasmin J-F, Frank PG, Lisanti MP, editors. Caveolins and caveolae: Roles in signaling and disease mechanisms. New York, New York: Landes Biosciences and Springer Science + Business Media. pp 83-94.
27. Pol A, Lu A, Pons M, Peiro S, Enrich C,. 2000. Epidermal growth factor- mediated caveolin recruitment to early endosomes and MAPK activation. Role of cholesterol and actin cytoskeleton. J Biol Chem 275 (39): 30566-30572.
28. Rao X, et al. 2013. CpG island shore methylation regulates caveolin-1 expression in breast cancer. Oncogene 32: 4519-4528.
29. Ridley AJ,. 2001. Rho family proteins: Coordinating cell responses. Trends Cell Biol 11 (12): 471-477.
30. Rose AE, Christos PJ, Darvishian F,. 2011. Clinical relevance of detection of lymphovascular invasion of primary melanoma using endothelial markers D2-40 and CD34. Am J Surg Pathol 35 (10): 1441-1448.
31. Rothberg KG, et al. 1992. Caveolin, a protein component of caveolae membrane coats. Cell 68 (4): 673-682.
32. Sahai E, Marshall CJ,. 2002. RHO-GTPases and Cancer. Nat Rev Cancer 2: 133-142.
33. Sedding DG, et al. 2005. Caveolin-1 facilitates mechanosensitive protein kinase B (Akt) signaling in vitro and in vivo. Circ Res 96 (6): 635-642.
34. Sequeira L, Dubyk CW, Riesenberger TA, Cooper CR, van Golen KL,. 2008. Rho GTPases in PC-3 prostate cancer cell morphology, invasion and tumor cell diapadesis. Clin Exp Metastasis 25: 569-579.
35. Shack S, et al. 2003. Caveolin-induced activation of the phosphatidylinositol 3-kinase/Akt pathway increases arsenite cytotoxicity. Mol Cell Biol 23 (7): 2407-2414.
36. Sloan EK, Stanley KL, Anderson RL,. 2004. Caveolin-1 inhibits breast cancer growth and metastasis. Oncogene 23 (47): 7893-7897.
37. Song KS, et al. 1996. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J BiolChem 271 (16): 9690-9697.
38. Suwa H, et al. 1998. Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas. Br J Cancer 77 (1): 147-152.
39. Van Laere SJ, Ueno NT, Finetti P, Vermeulen P, Lucci A, Robertson FM, Marsan M, Iwamoto T, Krishnamurthy S, Masuda H, van Dam P, Woodward WA, Viens P, Cristofanilli M, Birnbaum D, Dirix L, Reuben JM, Bertucci F,. 2013. Uncovering the molecular secrets of inflammatory breast cancer biology: An integrated analysis of three distinct Affymetrix gene expression data sets. Clin Cancer Res. 19 (17): 4685-4696.
40. Van den Eynden GG, et al. 2005. Overexpression of caveolin-1 and -2 in cell lines and human samples of inflammatory breast cancer. Breast Cancer Res Treat 95 (3): 219-228.
41. Van den Eynden GG, et al. 2006. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer. Breast Cancer Res Treat 95 (3): 219-228.
42. Wheeler AP, Ridley AJ,. 2004. Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility. Exp Cell Res 301 (1): 43-49.
43. Williams TM, et al. 2004. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J Biol Chem 279 (49): 51630-51646.
44. Woodward WA, Cristofanilli M,. 2009. Inflammatory breast cancer. Semin Radiat Oncol 19 (4): 256-265.
45. Yao H, Dashner EJ, van Golen CM, van Golen KL,. 2006. RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility. Oncogene 25 (16): 2285-2296.
46. van Golen KL, et al. 1999. A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. Clin Cancer Res 5 (9): 2511-2519.
47. van Golen KL, et al. 1999. A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. Clin Cancer Res 5 (9): 2511-2519.
48. van Golen KL, Wu ZF, Qiao XT, Bao LW, Merajver SD,. 2000. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. Cancer Res 60 (20): 5832-5838.
49. van Golen KL, et al. 2002. Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer. Clin Exp Metastasis 19 (4): 301-311.
50. van Golen KL,. 2006. Is caveolin-1 a viable therapeutic target to reduce cancer metastasis? Expert Opin Ther Targets 10 (5): 709-721.